Next |
home / stock / psti / psti message board
Subject | By | Source | When |
---|---|---|---|
Everything Passed At The Shareholders Meeting !!! | FDApproved | investorshub | 04/27/2023 8:15:33 PM |
Mesenchymal Stem/stromal Cells (MSCs) or exosomes for disease | FDApproved | investorshub | 04/27/2023 4:23:18 PM |
Hopefully they set up shop in Haifa just | Scott999 | investorshub | 04/27/2023 3:24:02 PM |
I Like It !!! | FDApproved | investorshub | 04/27/2023 2:36:08 PM |
It Looks Like AstraZenca Has Taken A Keen | FDApproved | investorshub | 04/27/2023 1:50:50 PM |
PluriMatrix!!! Oh the possibilities. Kakis been practicing his | Scott999 | investorshub | 04/27/2023 12:09:40 PM |
Cell Manufacturing Pioneer, Pluri Inc., Unveils PluriMatrix: a | FDApproved | investorshub | 04/27/2023 11:40:32 AM |
The turd also rises! | sekander | investorshub | 04/27/2023 1:17:34 AM |
And They Are Beautifully Indicative Of What's To | FDApproved | investorshub | 04/26/2023 11:01:21 AM |
The only thing PLUR has produced in their | sekander | investorshub | 04/26/2023 1:06:41 AM |
Is that from the same Phase 1 study | Scott999 | investorshub | 04/25/2023 5:31:39 PM |
Pluri's Avoplacel | FDApproved | investorshub | 04/25/2023 5:16:36 PM |
Good Insights !!! | FDApproved | investorshub | 04/21/2023 4:43:40 PM |
So are you still happy with management absolutely | Scott999 | investorshub | 04/20/2023 7:35:56 PM |
The eructations known as LMAO.999 aka Schadenfreude.999 is identified: | zzaatt | investorshub | 04/20/2023 1:48:41 PM |
A Nation Making Amends | FDApproved | investorshub | 04/19/2023 7:23:22 PM |
I guess Midas likes your posts! | zzaatt | investorshub | 04/19/2023 12:15:57 AM |
That you buying Zzatt? Trying to get to 300K? | Scott999 | investorshub | 04/18/2023 6:47:28 PM |
TWEET | FDApproved | investorshub | 04/18/2023 12:24:15 PM |
I was worried about you Zzatt. You never | Scott999 | investorshub | 04/18/2023 11:55:12 AM |
News, Short Squeeze, Breakout and More Instantly...
Pluristem Therapeutics Inc. Company Name:
PSTI Stock Symbol:
NASDAQ Market:
Pluristem Therapeutics Inc. Website:
HAIFA, Israel, July 25, 2022 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”) (formerly known as Pluristem Therapeutics, Inc.), a leading biotechnology company, today issued an update to its shareholders from its Chief Executi...
As of July 26 , 2022 , Pluri ’s stock will trade under the symbol PLUR The new name reflects the Company ’s strategy to leverage its innovative 3D cell-based technology to a range of fields, developing cel...
The Company will host an analyst and investor call to discuss the phase III muscle regeneration following hip fracture surgery topline results on July 14 at 9:00 a.m. ET; for registration: https://pluristem.zoom.us/webinar/register/WN_kp_CwQQtR-aFtjAXrdiJpA HAIFA, Israel, Ju...